CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 339 enrolled
Drug / intervention
Bio-Seal Plugdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00562302
NCT00562302Phase 3Completed
CompareCT.gov

A Prospective, Randomized, Multi-centered Safety and Efficacy Evaluation of the Bio-Seal Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy

Angiotech Pharmaceuticals·interventional·Posted Nov 22, 2007·Updated Mar 27, 2013

In Brief

A Phase 3 clinical trial evaluating Bio-Seal Plug for Pneumothorax. Completed, enrolled 339 participants across 18 sites.

Detailed Summary

BS-1053 A Prospective Randomized Multi-Centered Safety and Efficacy Evaluation of the Bio-Seal Biopsy Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy Procedures

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPneumothorax
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 22, 2007
Enrollment StartApr 1, 2005
Primary CompletionJun 1, 2008
Study CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 18.6 years ago

Interventions

Bio-Seal Plugdevice

Deployment of the Bio-Seal plug in needle track